API's
Active Pharmaceutical Ingredients
Active Pharmaceutical Ingredients
API
USP/EP
C8H14N2O2
(2S)-2-(2-oxopyrrolidin-1-yl)butanamide
102767-28-2
170.21 g/mol
pyrrolidone derivative
Anti-Convulsant
| Appearance | White to off-white crystalline powder |
|---|---|
| Solubility | Freely soluble in water; sparingly soluble in ethanol |
| Melting Point | 175–177 °C |
| pH | 5.0-7.0 |
Levetiracetam is an anticonvulsant medication used primarily to treat various types of seizures in epilepsy, including partial-onset, myoclonic, and generalized tonic-clonic seizures. It works by binding to the synaptic vesicle protein SV2A in the brain, which helps regulate neurotransmitter release and reduces abnormal neuronal activity that causes seizures. Known for its favorable safety profile and minimal drug interactions, levetiracetam is widely prescribed as a standalone treatment or as an add-on therapy for seizure control.
Levetiracetam works by binding to a specific protein called synaptic vesicle protein 2A (SV2A) in nerve cells. This binding helps regulate the release of neurotransmitters, which reduces the abnormal electrical activity in the brain that causes seizures, thereby helping to control and prevent them.
| Attribute | Why Salius Pharma Is a Good Choice |
|---|---|
| Quality Certification | WHO GMP, ISO 9001:2015, FDA audited facilities |
| Affordability & Generic Access | Cost competitive generics for global supply |
| Export Experience | Proven track record of supplying globally |
When you order from Salius Pharma, you receive more than just a product — you receive a complete, professionally prepared package that meets international regulatory and quality expectations.
We ensure prompt and reliable shipping worldwide. Delivery times vary depending on destination, order volume, and regulatory requirements.
7 to 21 business days from dispatch, depending on your location.
It is used to treat various types of seizures in epilepsy.
Levetiracetam works by binding to the synaptic vesicle protein 2A (SV2A) in the brain, which helps regulate the release of neurotransmitters and reduces abnormal electrical activity in nerve cells, preventing seizures.
It has minimal drug interactions but always inform your healthcare provider about other medications.
Yes, Salius Pharma Pvt. Ltd. exports Levetiracetam Active Pharmaceutical Ingredient (API) to countries in both Africa and the Middle East. As a Government of India-recognized Star Export House, Salius Pharma has established a strong international presence, supplying pharmaceutical APIs to various regions, including the Middle East and Africa.
Yes, Salius Pharma Pvt. Ltd. offers comprehensive technical support and regulatory documentation for Levetiracetam Active Pharmaceutical Ingredient (API). As a Government of India-recognized Star Export House, Salius Pharma has a dedicated Regulatory Affairs team that provides essential documentation and support to facilitate product registration and compliance with international standards.
Looking to source Levetiracetam or other high-quality pharmaceutical products?
We’re here to help.
Whether you need Active Pharmaceutical Ingredients (APIs), finished formulations, or regulatory support,
our team is ready to provide dependable, compliant, and cost-effective solutions tailored to your market needs.
The contents of this page and any attachments are intended solely for the designated recipient(s) and may contain confidential and/or privileged information protected by law.
Any patented products are excluded from our offerings in regions where such patents are currently in force.